How does RxFul pricing work?

Rx-GLP ($0/mo) is positioned as a funnel tier: GLP product access, a standard white-label template, pharmacy integration, 3PL fulfillment access, and a basic dashboard. It explicitly excludes peptides, custom packaging, advanced analytics, and API access. If your clinic prescribes hormones, peptides, or a wide formulary beyond GLP-1s, you start at Rx-Bronze ($997/mo), which unlocks the full SKU catalog, expanded branding, basic inserts, standard analytics, and cold-chain access.

Rx-Silver ($1,497/mo) adds full white-label customization, enhanced analytics, a marketing toolkit, volume-based fulfillment pricing, and priority support. Rx-Gold ($1,997/mo) is the max tier with dedicated onboarding, advanced reporting, API access, custom packaging runs, and priority allocation. RxFul states there are no affiliate commission differences across tiers — the jump is feature and fulfillment economics, not referral splits.

Fizy Health separates platform economics from drug cost differently. Access is always $0/mo with pass-through pricing and 9% facilitation, and resolved per-vial 503A cost appears on each catalog and cart line before checkout. You can model margin on semaglutide and tirzepatide the same day you sign up — without committing to a $997/mo catalog gate first.

That difference matters for cash-pay clinics. RxFul's published tiers tell you what the platform costs; they do not tell you what each vial costs. If you quote patients before onboarding, you are estimating drug COGS while already paying or planning for a monthly SaaS line. Pass-through pricing inverts that: see drug cost first, then decide whether added platform features justify any subscription.